EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma

EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma

http://www.wikidata.org/entity/Q28182609

about

NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane The scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent manner Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling Regulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factors PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility.The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.NHERF-1: modulator of glioblastoma cell migration and invasion Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.Engineering peptide inhibitors to overcome PDZ binding promiscuity.Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2.NHERF1/EBP50 in Breast Cancer: Clinical Perspectives PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control Cell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cells NHERF1/EBP50 is a new marker in colorectal cancer.The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1).Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1)Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients.EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration.Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus.SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation.In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.

P2860

Q24294023-37376248-313D-4390-88A0-963B671B592A Q24297357-E43A20B3-B891-464A-B20D-1623B1C34226 Q24298305-0F506CC6-D02F-4F81-8E17-554D637CF206 Q24302333-EB2D31C8-CC4D-4B19-9B96-DE2D224F2DA2 Q24306767-78D9A110-2465-4704-9A1C-0D0D4B08691C Q24323184-BD86AD7C-C34A-48F0-B735-B283403C5BE8 Q26863645-85D814F0-D38D-463B-B1C8-CA398BF60BA0 Q28115966-0213D6AE-2E70-4B21-87C9-1271FCF061E7 Q28576784-C02C1322-9389-4DA4-AC60-6C49C618B8C6 Q28588034-2D92D9C7-7556-4E7B-BA76-0A6751F5B884 Q30479197-3E166506-839B-466C-94EC-F84D0F91092E Q30479321-979F29C4-9749-469E-8514-9DC4BF17922C Q30625458-3FF72EFC-3988-4455-88BA-189D6BD66617 Q33302058-8FEC858E-D2B7-4E78-A9F2-5BDE0A1E36C0 Q33420852-88A2CE20-C3A6-40A1-BAAE-C2D950C018CC Q33597837-3EC36D51-50DF-4FD5-82E1-D03D0FFFB5DC Q33755113-1CF0FB2D-53B2-4FA4-8493-DE9A76EF3E5B Q33932203-078DA1A5-4055-4D7F-9B6F-7505D934D759 Q33962655-559D2277-E175-40AF-BD67-924A197A7302 Q34096013-986778AC-5B4B-453B-8F49-6E76A8ACCACE Q34202681-271A141E-F55D-4986-9E92-D0BE10EDE370 Q34241905-EC79F93A-B869-44B4-B8BF-B39F2EB62E8B Q34411711-D0FC0E32-E5A4-4724-9CB3-E7B46B13B4B7 Q35621438-9154F24E-DC2A-4783-94E5-530BAA9DE668 Q35633702-EFB30DD0-7141-4D08-9160-B6F6A4DD3DD5 Q35795744-B6B32E2F-3AA1-403A-93C6-55888C7F4061 Q35913641-03449D53-F969-4DF1-8421-CF4EA4FE38B4 Q36066974-619B500F-BC3F-421F-A6F3-8BE860E696D5 Q36214152-7CAF1158-1F6B-4960-BE7F-01A5E4CABB1C Q36288731-F43A70AC-B9DB-4938-8E9C-954EC41F0041 Q36319689-AAA4AC23-AF3A-45F7-A7DE-17D6D98EC828 Q36334877-61CF955D-EEFB-40AD-8C18-D77817AB9244 Q36392890-E7DF98B1-D0E9-4B43-8DB8-0F71BB9F9729 Q36536571-B5AEA8A7-445B-42C8-B6B6-58651DCFBAE5 Q36538416-15084D41-7B4B-476C-900D-3F792E3F9DE9 Q36808215-7D40EEF1-7561-4915-A734-EE355E127CF2 Q36962945-30C6CDFD-B241-488C-9512-BC3012C80203 Q37099496-4FA02412-2779-465C-9F66-01D5E386ADA6 Q37150777-8279D079-8A16-401E-8BE9-43DA6273586C Q37246058-44AFDBFE-795C-40DC-924F-5E6232AA6CAC

P2860

EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma

http://www.wikidata.org/entity/Q28182609

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@ast

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@en

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@nl

type

label

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@ast

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@en

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@nl

prefLabel

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@ast

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@en

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@nl

P1433

Q28182609-7D8833C4-3A61-47B8-AF56-8C43EF16554C

P1476

Q28182609-0253B23D-EEA7-41A4-8A44-B3C5ED3E92CF

P2093

Q28182609-36937843-8454-4C5D-914E-CEDE2FCA5E86

Q28182609-68773292-B4D0-4B29-8FBD-FE1A8E4A16A9

Q28182609-7FEE1D24-E2F1-45D0-B3AF-852ED6DDB935

Q28182609-E196B0E4-7FBC-4EDC-AB6A-3DB852CC06EB

Q28182609-E7478812-3E89-4D3D-B05D-262D42897B0F

P304

Q28182609-9E8C3BC1-BB75-4BB8-A59E-CEB61BA20B6C

P31

Q28182609-8DE69706-3C1C-4857-B88A-224D50EEB8E5

P3181

Q28182609-34E858A3-57BD-4169-B616-20D844A44586

P356

Q28182609-E398FE28-66FC-44B5-A3EB-5B88ABC1DA59

P407

Q28182609-21021832-2B48-41EC-8C9E-F231C88DDFE1

P433

Q28182609-E602CE91-DEFF-4540-8C26-E981AA011F97

P478

Q28182609-EC21A2A3-A686-46FB-B422-BD433FA8582F

P577

Q28182609-19E0F238-2315-4D8F-ADE0-9A691EE19C04

P5875

Q28182609-1D2ACCCD-FC00-44C1-BF7E-6F255A1DBA97

P698

Q28182609-7567F0D2-7C67-4B7D-B529-E3E1812CEF79

P3181

P356

JHEP.2003.50270

P1433

P1476

EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma

@en

P2093

Akiko Kokubu

http://www.w3.org/2001/XMLSchema#string

Makoto Chuma

http://www.w3.org/2001/XMLSchema#string

Michiie Sakamoto

http://www.w3.org/2001/XMLSchema#string

Setsuo Hirohashi

http://www.w3.org/2001/XMLSchema#string

Tatsuhiro Shibata

http://www.w3.org/2001/XMLSchema#string

P304

178-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4368390

http://www.w3.org/2001/XMLSchema#string

P356

10.1053/JHEP.2003.50270

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10687870

http://www.w3.org/2001/XMLSchema#string

P698

12830000

http://www.w3.org/2001/XMLSchema#string